Published: Apr 10, 2026
Written by Klarity Editorial Team
Published: Apr 10, 2026

If you’re struggling with binge eating disorder (BED), you’ve likely wondered whether you can access treatment from the comfort of your home. The good news: Yes, you can get evaluated and receive medication for binge eating disorder through telehealth — and it’s completely legal across the United States as of 2026.
With telehealth regulations now well-established and access expanding nationwide, understanding how online BED treatment works has never been more important. This comprehensive guide explains everything you need to know about getting medication for binge eating disorder through telemedicine, including what medications are available, which states allow it, and how to ensure you’re receiving safe, quality care.
Before diving into telehealth specifics, let’s clarify what binge eating disorder is and why medication might be part of your treatment plan.
Binge eating disorder is the most common eating disorder in the United States. According to DSM-5 diagnostic criteria, BED involves:
Importantly, BED diagnosis focuses on eating behaviors and psychological distress — not body weight or appearance. People of all sizes can have binge eating disorder.
Effective BED treatment typically involves a multidisciplinary approach:
Psychotherapy remains the gold standard, with cognitive behavioral therapy (CBT) showing particularly strong evidence for reducing binge episodes and improving psychological well-being.
Nutritional counseling helps establish regular eating patterns and address nutritional deficiencies or imbalances.
Medication can be a valuable tool, especially when combined with therapy. While only one medication (lisdexamfetamine/Vyvanse, a controlled stimulant) has FDA approval specifically for BED, several non-controlled medications are commonly prescribed off-label with good clinical evidence supporting their use.
This is where telehealth becomes especially relevant — connecting you with prescribers who can evaluate your condition and, when appropriate, prescribe medication as part of a comprehensive treatment plan.
Understanding the regulatory framework helps you navigate telehealth with confidence. Here’s what you need to know.
The critical distinction for BED treatment is that the most commonly prescribed telehealth medications — Topamax (topiramate) and Wellbutrin (bupropion) — are not controlled substances. This means they’re not subject to the strict Ryan Haight Act restrictions that govern controlled medication prescribing.
Under federal law, these non-controlled medications can be prescribed via telehealth without any mandatory in-person examination. The temporary COVID-19 prescribing flexibilities that made headlines primarily affect controlled substances (like ADHD medications or pain medications), not the medications typically used for BED.
As of January 2026, the DEA has extended telehealth prescribing flexibilities for controlled substances through December 31, 2026. However, for non-controlled medications like those commonly used for binge eating disorder, these flexibilities were never needed — telehealth prescribing has always been permitted under federal law.
While federal law sets the baseline, individual states can add their own requirements. The good news: most states have removed or never had in-person requirements for non-controlled medication prescribing via telehealth.
Here’s what the current state landscape looks like:
States with no in-person requirement whatsoever (for non-controlled meds like BED treatments):
States requiring periodic in-person visits for ongoing telehealth treatment:
Even in states with periodic requirements, the initial evaluation and prescription can typically be done entirely via telehealth. The in-person requirement applies only to long-term continuation of care, and can often be satisfied by seeing any local provider — not necessarily your telehealth prescriber.
Bottom line: If you’re seeking medication for binge eating disorder through a legitimate telehealth platform in 2026, you can access care in every U.S. state. Your provider must be licensed in your state, but the evaluation, prescription, and follow-up care can all typically happen online.
Let’s explore the specific medications you might encounter when seeking telehealth treatment for BED.
What it is: Topiramate is an anticonvulsant medication FDA-approved for seizure disorders and migraine prevention. For binge eating disorder, it’s prescribed off-label.
How it helps BED: Research suggests topiramate can reduce binge eating frequency and promote modest weight loss. It appears to work by affecting impulse control and reducing food cravings, though the exact mechanism isn’t fully understood.
Telehealth accessibility: ✅ Fully available — Topiramate is not a controlled substance, so it can be prescribed via telehealth in all 50 states without special restrictions.
Starting treatment: Providers typically start at low doses (25mg) and gradually increase to minimize side effects. Common dosing for BED ranges from 50-200mg daily, though this varies individually.
Important considerations:
Typical prescription: 90-day supply with refills (common for non-controlled medications), though initial prescriptions may be shorter while titrating dose.
What it is: Bupropion is an atypical antidepressant FDA-approved for depression and smoking cessation. It’s also used off-label for BED.
How it helps BED: Bupropion appears to reduce binge eating frequency and can help with mood symptoms that often co-occur with BED (like depression or anxiety). It may work by affecting dopamine and norepinephrine systems in the brain.
Telehealth accessibility: ✅ Fully available — Like topiramate, bupropion is not controlled and can be prescribed via telehealth nationwide.
Starting treatment: Common starting dose is 150mg once or twice daily (extended-release formulation). Your provider may adjust based on response and tolerability.
Important considerations:
Typical prescription: 90-day supply with refills, with scheduled follow-up visits to monitor effectiveness and safety.
You may have heard of lisdexamfetamine (Vyvanse) — it’s the only FDA-approved medication specifically for binge eating disorder. However, Vyvanse is a Schedule II controlled substance (stimulant medication).
Current federal regulations for controlled substances require more stringent protocols for telehealth prescribing. While the temporary COVID flexibilities allow some controlled substance prescribing via telehealth through December 2026, most reputable telehealth platforms do not prescribe stimulants for BED due to:
If during your telehealth evaluation it becomes clear you might benefit from Vyvanse or another controlled medication, your provider will typically refer you to an in-person specialist.
Understanding who’s authorized to prescribe helps you evaluate telehealth providers.
Medical doctors and doctors of osteopathy can prescribe these medications via telehealth in any state where they’re licensed. No restrictions apply to non-controlled BED medications.
Nurse practitioners represent a growing segment of telehealth providers, and in 2025-2026, their prescribing authority has expanded significantly:
Full Practice Authority states (34+ states plus DC): In states like California, New York, New Hampshire, Michigan, Wisconsin, and many others, NPs can independently evaluate, diagnose, and prescribe medications for BED without physician oversight. Recent additions to this list (2023-2025) include Louisiana, Kansas, Wisconsin, and Michigan.
Collaborative/Supervisory states: In states like Texas, Florida, Georgia, and Alabama, NPs must work under a collaborative agreement with a physician. This doesn’t prevent them from prescribing Topamax or Wellbutrin for BED — it’s simply a behind-the-scenes regulatory requirement. You might see both the NP and supervising physician listed on documentation.
What this means: Whether you see an NP or physician via telehealth, you can receive the same quality care for BED medication management. The collaboration requirement (where it exists) is administrative and shouldn’t affect your treatment experience.
Similar to NPs, physician assistants can prescribe non-controlled medications under their scope of practice. PAs typically work under physician supervision in all states, but this doesn’t limit their ability to prescribe medications like topiramate or bupropion for BED through telehealth platforms.
At Klarity Health, you’ll connect with licensed psychiatrists, psychiatric nurse practitioners, and other qualified mental health prescribers — all credentialed to provide medication management for binge eating disorder in your state. Our providers work collaboratively to ensure you receive comprehensive care aligned with the latest clinical guidelines.
Understanding what happens during a telehealth BED evaluation helps you prepare and ensures you’re working with a legitimate provider.
A proper telehealth evaluation for BED should be thorough and detailed — typically 30-45 minutes for an initial consultation. Red flag if a service rushes through in 5-10 minutes and immediately offers prescriptions.
Your provider will ask about:
Eating patterns and behaviors:
Mental health history:
Medical history:
Diagnostic screening:Many providers use validated questionnaires like:
These help ensure you meet DSM-5 criteria for BED and screen for co-occurring conditions.
Before prescribing, your provider should:
Explain medication options — Including that topiramate and bupropion are used off-label for BED (meaning they’re not FDA-approved for this specific condition, but have clinical evidence supporting their use)
Discuss risks and benefits — Including potential side effects, contraindications, and what to expect from treatment
Review alternatives — Legitimate providers will mention psychotherapy, nutritional counseling, and other approaches, not just push medication
Obtain informed consent — You’ll sign telehealth-specific consent forms acknowledging you understand the limitations and benefits of virtual care
Create a follow-up plan — Scheduling check-ins to monitor progress and safety
Reputable telehealth platforms will:
Verify your identity and location — Required by many state laws and necessary to confirm the provider is licensed in your state
Review medication history — While not legally required for non-controlled medications, many providers check your state’s Prescription Monitoring Program (PMP) as a safety precaution to identify potential drug interactions or duplications
Screen for contraindications — Ensuring you don’t have conditions that would make these medications unsafe (like seizure disorders for bupropion, or pregnancy for topiramate)
Document thoroughly — Creating detailed records just as they would for in-person visits
The telehealth boom has brought both expanded access and occasional quality concerns. Here’s how to ensure you’re receiving safe, appropriate care.
Honest, quality providers will tell you when telehealth isn’t the right fit. You may need in-person care if:
You have contraindications to available medications:
You need controlled medications:
Medical instability requires hands-on evaluation:
You have active suicidal ideation:
Co-occurring substance use disorders:
Be cautious if a telehealth service:
❌ Guarantees prescriptions before evaluation — Legitimate providers can’t promise medication until they’ve assessed whether it’s appropriate for you
❌ Skips comprehensive evaluation — 5-minute questionnaires aren’t sufficient to diagnose BED or prescribe medication safely
❌ Doesn’t discuss non-medication options — Standard care includes at least mentioning therapy and nutritional approaches
❌ Starts multiple medications simultaneously — Safe practice is starting one medication at a time at low doses
❌ Ships medication directly — Legitimate prescriptions should go to licensed pharmacies (retail or mail-order), not ship in unmarked packages from the platform itself
❌ Doesn’t provide clear provider credentials — You should know who’s prescribing (name, credentials, license state)
❌ Lacks follow-up protocols — Ongoing monitoring is essential; one-and-done prescribing without scheduled check-ins is irresponsible
❌ Promises unrealistic results — Claims of guaranteed weight loss or ‘curing’ BED are unethical and medically inaccurate
In contrast, reputable services like Klarity Health demonstrate quality through:
✅ Licensed, credentialed providers in your state✅ Comprehensive evaluations that take adequate time✅ Transparent pricing with no hidden fees✅ Clear follow-up schedules with accessible provider communication✅ Integration options — helping coordinate with your therapist, primary care doctor, or nutritionist✅ Acceptance of insurance (when available) alongside cash-pay options✅ Evidence-based treatment aligned with clinical guidelines✅ Patient safety protocols including screening for contraindications and medication interactions
At Klarity, we match you with a provider who has availability within 24-48 hours, ensuring you don’t wait weeks for care. Our transparent pricing means you know costs upfront, and we accept both insurance and self-pay, making treatment accessible regardless of your coverage situation.
Once your provider determines medication is appropriate:
Electronic prescribing: Your prescription will be sent electronically to the pharmacy of your choice — whether that’s your local retail pharmacy or a mail-order option
Filling the prescription: You pick it up (or receive it by mail) just like any other prescription. For non-controlled medications like topiramate or bupropion, there’s no special DEA paperwork or limitations
Refills: Providers can authorize multiple refills (typically up to 6-11 months depending on state regulations), though you’ll still have scheduled follow-ups to monitor progress
Insurance coverage: These medications are generally well-covered by insurance when prescribed for any indication. Some plans may require prior authorization or step therapy (trying other treatments first)
Cost without insurance: Generic topiramate and bupropion are relatively affordable — often $10-50/month at major pharmacies or through discount programs like GoodRx
Expect regular check-ins with your telehealth provider:
Initial titration period (first 1-2 months):
Maintenance phase:
Long-term management:
Emergency access:
Your provider should regularly reassess whether medication is helping:
Continuing medication: If binge frequency decreases and you’re tolerating the medication well, treatment continues with monitoring
Adjusting dose: If response is partial, your provider may increase the dose (within safe limits) or try extended-release formulations
Switching medications: If you can’t tolerate one medication, trying the other option (topiramate vs. bupropion) is reasonable
Adding therapy: Medication works best combined with psychotherapy — your provider may help connect you with a therapist if you’re not already in therapy
Discontinuing medication: If you achieve sustained improvement, you and your provider might discuss gradually tapering off medication (don’t stop abruptly, especially with topiramate, due to seizure risk)
Referral to specialists: If telehealth treatment isn’t sufficient, referral to eating disorder specialists, intensive outpatient programs, or other levels of care may be needed
While the general landscape is favorable for telehealth BED treatment, a few states have specific nuances worth noting:
Alabama: After 4 telehealth visits within 12 months for the same condition, providers must see you in person (or arrange for you to see a collaborating provider) within that year. This applies to ongoing treatment — initial prescribing can be entirely virtual.
Georgia: Requires an attempt at annual in-person examination for continued telemedicine care. Providers must document this attempt, though if you can’t make an in-person visit, care can often continue with proper documentation.
New Hampshire: New law (effective August 2025) allows Schedule II-IV medications via telehealth but requires annual in-person follow-up. For non-controlled BED meds, this doesn’t apply, but the state’s general approach favors some in-person contact for ongoing care.
Practical tip: If you live in these states, you might schedule an annual visit with a local provider (like your primary care doctor) to satisfy this requirement while continuing telehealth care with your BED specialist.
California: Explicitly allows asynchronous telehealth (questionnaire-based) to count as an appropriate examination when it meets standard of care. Very permissive telehealth environment.
New York: No in-person requirement for non-controlled medications. New 2025 rules requiring in-person for controlled substances actually emphasize that non-controlled meds remain freely prescribable via telehealth.
Delaware: Passed legislation in July 2025 further clarifying telehealth access for medication-assisted treatment and other care — one of the most telehealth-friendly states.
Remember: Your telehealth provider must be licensed in the state where you’re physically located during the appointment, not just where the company is based. Reputable platforms verify your location and ensure appropriate provider matching.
Some providers hold licenses in multiple states, expanding their ability to see patients. Others partner with local providers in each state they serve.
While this guide focuses on medication access, it’s important to emphasize that medication alone is rarely sufficient for binge eating disorder.
Cognitive behavioral therapy (CBT) specifically designed for BED has the strongest evidence base of any treatment. CBT helps you:
Many therapists now offer telehealth services as well, making it possible to receive completely virtual comprehensive care.
Working with a registered dietitian who specializes in eating disorders helps:
Even when treatment is primarily telehealth-based, periodic check-ins for:
…may be appropriate, especially if you have co-occurring health conditions.
Peer support groups (like Overeaters Anonymous or NEDA support groups) provide community and understanding that complement professional treatment.
Klarity Health’s approach: While we specialize in medication management via telehealth, our providers can help coordinate your comprehensive care, providing referrals to therapists, nutritionists, and other specialists as appropriate. We believe medication works best as one component of a holistic treatment plan.
The telehealth landscape continues to evolve, generally in favor of expanded access:
Stabilization of telehealth rules: After years of temporary pandemic-era waivers, states are increasingly making telehealth flexibilities permanent. The trend is toward maintaining or expanding access, not restricting it.
Controlled substance rules pending: The DEA’s final rule on telehealth prescribing of controlled substances (expected by late 2026) will clarify long-term access to medications like Vyvanse. Advocacy groups are pushing for rules that balance safety with access.
Nurse practitioner scope expansion: More states are granting full practice authority to NPs, expanding the pool of providers who can independently treat BED via telehealth.
Better platforms: Telehealth technology continues improving, with better video quality, integrated patient portals, and seamless pharmacy connections.
Hybrid models: Some providers offer ‘hybrid’ care — initial evaluation in person, then telehealth follow-ups, or vice versa. This may satisfy state requirements while maintaining convenience.
Measurement-based care: Digital tools that track binge frequency, mood, and other symptoms between appointments help providers make more informed treatment decisions.
Telehealth parity laws (requiring insurers to cover telehealth the same as in-person care) continue expanding. This means fewer barriers to accessing affordable online treatment.
If you’re ready to explore telehealth treatment for binge eating disorder:
Look for services that:
Klarity Health checks all these boxes. We connect you with licensed mental health prescribers who specialize in conditions like binge eating disorder, with appointments available within 24-48 hours. Our transparent pricing means no surprise bills, and we accept both insurance and self-pay options to make care accessible.
Before your evaluation:
Your provider can only help if they have accurate information. Share openly about:
Everything discussed is confidential and protected by HIPAA privacy laws.
While seeking medication, also think about:
Many people find the combination of medication, therapy, and nutritional counseling most effective.
Treatment works best when you:
If you’re struggling with binge eating disorder, help is available — and it’s more accessible than it’s ever been.
The key takeaways:
✅ Medication for BED can be prescribed via telehealth in all 50 states using non-controlled options like topiramate (Topamax) and bupropion (Wellbutrin)
✅ No in-person visit required in most states to start treatment — the evaluation, prescription, and follow-up can all happen online
✅ Licensed providers (MDs, DOs, NPs, PAs) can legally and safely prescribe these medications through legitimate telehealth platforms
✅ Safety and quality matter — choose reputable services that conduct comprehensive evaluations and provide ongoing care
✅ Medication works best as part of comprehensive treatment that includes therapy, nutritional support, and lifestyle approaches
The expansion of telehealth has removed many barriers that once prevented people from accessing eating disorder treatment — geography, scheduling challenges, stigma associated with in-person visits, and limited local specialist availability.
Klarity Health is here to connect you with experienced providers who understand binge eating disorder and offer evidence-based treatment through convenient, affordable telehealth appointments. With provider availability within 24-48 hours, transparent pricing, and acceptance of both insurance and self-pay, we’ve made it easier than ever to take the first step toward recovery.
You don’t have to struggle alone. Effective treatment is just a video call away.
Ready to get started? Visit Klarity Health today to schedule your confidential evaluation with a licensed mental health provider who can help you develop a personalized treatment plan for binge eating disorder — all from the comfort and privacy of your own home.
U.S. Department of Health and Human Services. (2026). DEA extends telehealth prescribing flexibilities through December 31, 2026. Retrieved from https://www.hhs.gov/press-room/dea-telemedicine-extension-2026.html
Sheppard, Mullin, Richter & Hampton LLP. (2025). Telehealth and in-person visits: Tracking federal and state updates to pandemic-era telehealth exceptions. Retrieved from https://www.sheppardhealthlaw.com/2025/08/articles/telehealth/telehealth-and-in-person-visits-tracking-federal-and-state-updates-to-pandemic-era-telehealth-exceptions/
Center for Connected Health Policy. (2025). State telehealth laws and reimbursement policies: Online prescribing. Retrieved from https://www.cchpca.org/topic/online-prescribing/
Health Jobs Nationwide. (2025). State-by-state guide: Expanding roles for PAs and NPs – Updated 2025. Retrieved from https://blog.healthjobsnationwide.com/state-by-state-guide-expanding-roles-for-pas-and-nps-updated-2025/
DailyMed, U.S. National Library of Medicine. Bupropion hydrochloride extended-release tablets – FDA label. Retrieved from https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=1b69c253-4740-44b0-be63-6c20834540b6&type=display
📅 RESEARCH CURRENCY STATEMENT
Verified as of: January 4, 2026
DEA Rules Status: COVID-19 telehealth prescribing flexibilities remain in effect through December 31, 2026 (fourth extension). No federal in-person requirement exists for non-controlled medications — these were never subject to the Ryan Haight Act restrictions on telemedicine.
States Verified: Researched 10+ key states (AL, CA, DE, FL, GA, NH, NY, TX, MI, WI, etc.) with latest information as of late 2025. State board sites and 2025 legislative updates were checked where available.
Sources Currency: 80%+ of sources are from 2025 (many late-2025) or updated to reflect 2025 regulations. Older sources (2024) were used only when confirmed still accurate by newer references.
⚠️ Flagged for Follow-Up: Alabama and South Carolina NP scope changes (legislation was discussed in 2025 but final status unclear — assume no full independence yet pending confirmation). Monitor DEA’s pending final rule on telehealth prescribing (expected by end of 2026). Verify any temporary state waivers for expiration/extension beyond 2025.
Find the right provider for your needs — select your state to find expert care near you.